Department of Medical Imaging, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Division of Diagnostic and Therapeutic Neuroradiology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
Neuroradiol J. 2023 Dec;36(6):686-692. doi: 10.1177/19714009231177359. Epub 2023 May 21.
Timely restoration of cerebral blood flow using reperfusion therapy is the most effective maneuver for salvaging penumbra. We re-evaluated the previously described PROTECT (PRoximal balloon Occlusion TogEther with direCt Thrombus aspiration during stent retriever thrombectomy) Plus technique at a tertiary comprehensive stroke center.
We retrospectively analyzed all patients who underwent mechanical thrombectomy with stentrievers between May 2011 and April 2020. Patients were divided between those who underwent PROTECT Plus and those who did not (proximal balloon occlusion with stent retriever only). We compared the groups in terms of reperfusion, groin to reperfusion time, symptomatic intracranial hemorrhage (sICH), modified Rankin Scale (mRS) score at discharge.
Within the study period, 167 (71.4%) PROTECT Plus and 67 (28.6%) non-PROTECT patients which met our inclusion criteria. There was no statistically significant difference in the number of patients with successful reperfusion (mTICI >2b) between the techniques (85.0% vs 82.1%; = 0.58). The PROTECT Plus group had lower rates of mRS ≤2 at discharge (40.1% vs 57.6%; = 0.016). The rate of sICH was comparable ( = 0.35) between the PROTECT Plus group (7.2%) and the non-PROTECT group (3.0%).
The PROTECT Plus technique using a BGC, a distal reperfusion catheter and stent retriever is feasible for recanalization of large vessel occlusions. Successful recanalization, first-pass recanalization and complication rates are similar between PROTECT Plus and non-PROTECT stent retriever techniques. This study adds to an existing body of literature detailing techniques that use both a stent retriever and a distal reperfusion catheter to maximize recanalization for patients with large vessel occlusions.
通过再灌注治疗及时恢复脑血流是挽救缺血半暗带最有效的手段。我们在一家三级综合卒中中心重新评估了之前描述的 PROTECT(近端球囊闭塞联合直接血栓抽吸与支架取栓术)加技术。
我们回顾性分析了 2011 年 5 月至 2020 年 4 月期间接受支架取栓机械血栓切除术的所有患者。患者分为接受 PROTECT 加技术和未接受 PROTECT 加技术(仅近端球囊闭塞与支架取栓术)的两组。我们比较了两组的再灌注、股动脉至再灌注时间、症状性颅内出血(sICH)和出院时改良 Rankin 量表(mRS)评分。
在研究期间,符合纳入标准的 167 例(71.4%)PROTECT 加技术和 67 例(28.6%)非 PROTECT 患者。两种技术的成功再灌注(mTICI >2b)患者数量无统计学差异(85.0%比 82.1%;=0.58)。PROTECT 加技术组出院时 mRS≤2 的比例较低(40.1%比 57.6%;=0.016)。sICH 发生率在 PROTECT 加技术组(7.2%)和非 PROTECT 组(3.0%)之间无差异(=0.35)。
使用 BGC、远端再灌注导管和支架取栓术的 PROTECT 加技术对于大血管闭塞的再通是可行的。PROTECT 加技术和非 PROTECT 支架取栓技术的再通成功率、初次通过再通率和并发症发生率相似。本研究增加了现有文献中详细描述使用支架取栓和远端再灌注导管来最大限度地使大血管闭塞患者再通的技术。